[Federal Register Volume 89, Number 201 (Thursday, October 17, 2024)]
[Notices]
[Pages 83688-83689]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-23885]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Meeting of the Advisory Council for the Elimination of 
Tuberculosis

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC) announces the 
following meeting of the Advisory Council for the Elimination of 
Tuberculosis (ACET). This meeting is open to the public, limited only 
by the number of audio and web conference lines (1,000 lines are 
available). Time will be available for public comment (registration is 
required to provide oral comment; see the Oral Public Comment section 
below).

DATES: The meeting will be held on December 3, 2024, from 9:30 a.m. to 
4:30 p.m., EST, and December 4, 2024, from 10 a.m. to 12 p.m., EST.
    Written comments must be submitted by November 26, 2024. 
Registration to make oral comments must also be submitted by November 
26, 2024.

ADDRESSES: The public meeting will be held virtually through Zoom. 
Registration in advance is required to attend. Please visit https://cdc.zoomgov.com/webinar/register/WN_1bRtm_1MRoiz83dFlQoHQQ to register. 
This registration for virtual attendance will remain open through the 
meeting. Prior to the meeting, each individual registrant will receive 
a registration confirmation along with an access link to the virtual 
meeting location.

FOR FURTHER INFORMATION CONTACT: Marah Condit, M.S., Committee 
Management Lead, Office of Policy, Planning, and Partnerships, National 
Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for 
Disease Control and Prevention, 1600 Clifton Road NE, Mailstop US8-6, 
Atlanta, Georgia 30329-4027. Telephone: (404) 639-3423; Email: 
<a href="/cdn-cgi/l/email-protection#1e707d76766d6a6e6e7172777d675e7d7a7d30797168"><span class="__cf_email__" data-cfemail="650b060d0d161115150a090c061c250601064b020a13">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: 
    Purpose: The Advisory Council for the Elimination of Tuberculosis 
is charged with providing advice and recommendations regarding the 
elimination of tuberculosis (TB) to the Secretary of Health and Human 
Services, the Assistant Secretary for Health, and the Director, Centers 
for Disease Control and Prevention (CDC). Specifically, the Council 
makes recommendations regarding policies, strategies, objectives, and 
priorities; addresses the development and application of new 
technologies; provides guidance and review on CDC's Tuberculosis 
Prevention Research portfolio and program priorities; and reviews the 
extent to which progress has been made toward eliminating TB.
    Matters to be Considered: The agenda will include discussions on: 
(1) CDC's National Center for HIV, Viral Hepatitis, STD, and TB 
Prevention Update; (2) CDC's Division of Tuberculosis Elimination 
Update; (3) TB in New Arrivals; (4) CDC's National Tuberculosis 
Surveillance System and Molecular Surveillance; (5) Tuberculosis 
Epidemiologic Studies Consortium III; (6) Think. Test. Treat TB 
Campaign; (7) Laboratory Developed Tests Workgroup Update; and (8) Drug

[[Page 83689]]

Shortage Workgroup Update. Agenda items are subject to change as 
priorities dictate.

Public Participation

    Written Public Comment: Members of the public are welcome to submit 
written comments in advance of the meeting. Written comments must be 
submitted by emailing <a href="/cdn-cgi/l/email-protection#e38d808b8b909793938c8f8a809aa3808780cd848c95"><span class="__cf_email__" data-cfemail="94faf7fcfce7e0e4e4fbf8fdf7edd4f7f0f7baf3fbe2">[email protected]</span></a> with subject line ``ACET 
December 2024 Public Comment Registration'' by November 26, 2024.
    Oral Public Comment: Individuals who would like to make an oral 
comment during the public comment period must register by emailing 
<a href="/cdn-cgi/l/email-protection#90fef3f8f8e3e4e0e0fffcf9f3e9d0f3f4f3bef7ffe6"><span class="__cf_email__" data-cfemail="e18f828989929591918e8d888298a1828582cf868e97">[email protected]</span></a> with subject line ``ACET December 2024 Public 
Comment Registration'' by November 26, 2024. The public comment period 
is on December 4, 2024, at 10:15 a.m., EST.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-23885 Filed 10-16-24; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>